Bayer stock analysis
Bayer (BAY) Stock Price & Analysis
BAY Stock Chart & Stats
- Day’s Range
- PLN 248.70 - PLN 251.70
- 52-Week Range
- PLN 108.00 - PLN 251.70
- Previous Close
- PLN 246.90
- Volume
- N/A
- Average Volume (3M)
- 36
- Market Cap
- PLN 244.80B
- Enterprise Value
- PLN 84.40B
- Total Cash (Recent Filing)
- PLN 12.60B
- Total Debt (Recent Filing)
- PLN 43.42B
- Price to Earnings (P/E)
- ―
- Beta
- 0.53
- Next Earnings
- Feb 24, 2027 (Est.)
- EPS Estimate
- 2.63
- Last Dividend Ex-Date
- Apr 27, 2026
- Dividend Yield
- 0.19%
Bulls Say, Bears Say
Bulls Say
Pharmaceutical Pipeline Momentum
The China approval gives Bayer a meaningful pipeline asset and expands its pharmaceutical growth options beyond existing products. Asundexian’s first-in-class status may support further regulatory filings, future commercialization, and a broader platform for rebuilding durable Pharma growth.
Positive Operating Cash Generation
Consistently positive operating cash flow shows that Bayer’s established Pharmaceuticals and Crop Science businesses continue to generate liquidity from operations. This provides an internal funding base for research, debt reduction, and investment, even though recent free-cash-flow performance has weakened.
Improving Operating Outlook
The upgraded guidance indicates improving execution and gives greater support to Bayer’s near-term operating trajectory. Higher expected EBITDA and better cash guidance could strengthen financial flexibility, while management’s focus on productivity and balance-sheet improvement supports longer-term recovery.
Bears Say
Recurring Net Losses
Repeated net losses indicate that Bayer’s substantial revenue base is not consistently converting into shareholder earnings. Persistent bottom-line weakness can constrain reinvestment, reduce financial flexibility, and make future performance more dependent on successful cost, portfolio, and pipeline execution.
Sharp Free-cash-flow Deterioration
The steep decline in free cash flow signals weaker cash conversion or materially higher cash outflows, reducing confidence in the durability of internally generated funds. This can limit debt reduction and investment capacity while increasing pressure on management to restore cash generation.
High Financial Leverage
Bayer’s historically elevated leverage reduces resilience while earnings remain weak and cash flow is volatile. A large debt burden can absorb operating cash through financing obligations, constrain capital allocation, and leave less flexibility to fund pipeline development or withstand business pressure.
BAY FAQ
What was Bayer’s price range in the past 12 months?
What is Bayer’s market cap?
When is Bayer’s upcoming earnings report date?
How were Bayer’s earnings last quarter?
Is Bayer overvalued?
Does Bayer pay dividends?
What is Bayer’s EPS estimate?
How many shares outstanding does Bayer have?
What happened to Bayer’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Bayer?
What is the TipRanks Smart Score and how is it calculated?
Bayer Stock Smart Score
Company Description
Bayer
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
- Sector
- General
- Industry
- Drug Manufacturers - General
- CEO
- Bill Anderson
- Employees
- 87,775
- Website
- www.bayer.com
- Address
- Kaiser-Wilhelm-Allee 1, Leverkusen, NW, 51368, DE
Bayer (BAY) Earnings & Revenues
BAY Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 1 | 7 |
| Technical Analysis | 2 | 1 | 7 |
| Moving Averages | 12 | 0 | 0 |
